Buprenorphine transdermal delivery system

DRUG6 trials

Sponsors

Purdue Pharma LP

Conditions

Back PainChronic Low Back PainChronic PainOsteoarthritisPostoperative Pain

Phase 2

Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.

CompletedNCT00315835

Purdue Pharma LPPostoperative Pain

Start: 1996-10-31End: 1997-11-30Target: 100Updated: 2006-04-19

Phase 3

Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study.

CompletedNCT00313833

Purdue Pharma LPChronic Pain

Start: 2000-12-31End: 2001-11-30Target: 100Updated: 2006-05-03

Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

CompletedNCT00314652

Purdue Pharma LPOsteoarthritis

Start: 1999-06-30End: 1999-10-31Target: 260Updated: 2006-05-03

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

CompletedNCT00315848

Purdue Pharma LPOsteoarthritis

Start: 1996-11-30End: 1999-12-31Target: 225Updated: 2006-05-03

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain.

CompletedNCT00315887

Purdue Pharma LPChronic Low Back Pain

Start: 1999-04-30End: 1999-10-31Target: 250Updated: 2006-05-03

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Low Back Pain.

CompletedNCT00315874

Purdue Pharma LPBack Pain

Start: 1997-04-30End: 1998-01-31Target: 225Updated: 2013-05-14